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Although compartment models are frequently used in pharmacokinetics, it is difficult to find 
complete analytical formulas describing the behaviour of drugs in universal simpler 
compartment models in the accessible literature. The paper presents derivations of formulas 
for general two- and three-compartment models, including the possibilities of original non-
zero quantity in all compartments and elimination from all compartments. Formulas for four-
compartment models are also derived with the restriction that original quantity is non-zero in 
only one compartment. Derivation uses Laplace transformation but does not require prior 
knowledge of the technique. The derived analytical formulas are verified numerically. These 





To describe and understand the pharmacokinetics of a drug, it is very often useful to set up a 
model and determine the model parameters best fitting the data. Compartment models are 
useful tools in this respect; however, it is difficult to find complete analytical formulas 
describing the behaviour of drugs in universal simpler compartment models. A three-
compartment model (3-C) is frequently mentioned in the literature; however, the accessible 
references are limited for mammillary models and present complete formulas neither for 
catenary nor for cyclic models [1, 2, 3, 4, 5]. The accessible literature for four-compartment 
models (4-C) also does not present the final complete equations [6, 7]. Although the formulas 
for two-compartment models (2-C) are better known, they will be presented here as well for a 
better demonstration of the derivation method.  
 
The purpose of the paper is to give a derivation of the concentration formulas for 2-C, 3-C, 
and 4-C models, in a form accessible to readers knowledgeable of compartment models and 
not scared by math, but without assuming prior knowledge of advanced techniques such as 
Laplace transformations. In Supplementary Material, the results are presented as computer 
algorithms to make the formulas easier applicable for the readers. These algorithms are 
implemented in PHP, but, after minor changes, can be used in other software languages as 
well.   
The treatment will be general, except that it will be assumed that all drug has entered the 
system at time t=0. While this restriction excludes cases where drugs are introduced 
gradually, it can be circumvented for cases where further drug is introduced at specific time 
points t1, t2, etc.: First the problem is solved from 0 until t1, then using the final quantities + 
newly introduced drug is used to solve from t1 to t2, etc.  
 
 
Briefly on compartment models 
 
In modelling, a compartment is used to specify where (e.g. in the plasma) or in what state 
(e.g. free or bound) the discussed substance is distributed. As such, pharmacokinetic 
compartments do not necessarily correspond to structurally delineated anatomic 
compartments. Compartment modelling assumes uniform distribution within each 
compartment, i.e. that each compartment can be assigned a concentration. After the drug has 
entered the system (e.g. by injection), the concentration in a given compartment at time t can 











       {eq. 1} 
where n is the number of compartments in the system.  
 
Having the above formula, the area under the time-concentration curve (AUC) in the 








/ .        {eq. 2} 
In the specific case of a 2-C model, a common notation is to write A·exp(-α·t) + B·exp(-β·t) 
rather than c1·exp(-b1·t) + c2·exp(-b2·t). In this case, 
 AUC = A/α + B/β.        {eq. 3} 
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The exponentials describe the overall behaviour of the system. This behaviour arises from the 
inherent parameters of the model: elimination rate constants, clearances, and compartment 
volumes. These parameters are sometimes referred to as micro-constants. 
 
In the models considered here, the rate of the transport of a drug (quantity per time) is 
proportional to its concentration in the respective compartment (linear models, first order 
processes). The transport rate constants (k) are signed with lower indices describing the 
direction of the transport, i.e., kij denotes elimination rate constant from compartment i to j, kji 
from j to i, ki0 from compartment i to the environment (and, hence, from the entire organism). 
In passive transport, there is no preferred direction of transport, leading to the following 
dependence: 
 ijjjiiij ClVkVk == ,      {eq. 4} 
where Clij is the intercompartmental clearance (the same in both directions) and Vi is the 
volume of the compartment i. Additionally, Qti and Cti denote the quantity and concentration, 
respectively, of the drug in compartment i in a given time point t. Similarly, Qi0 is its initial 
amount, and Ci0 its initial concentration in compartment i.  
 
By definition, a single compartment has only a single concentration, corresponding to 
assuming instantaneous mixing of the injected drug with the entire volume of the 
compartment. If that assumption is a problem in a given context, then a different model is 
needed, e.g. a compartment models where the “problematic” compartment is represented by 




Introduction to Laplace transformation 
 
A compartment model can be described with a system of differential equations in which the 
behaviour of the drug in each compartment is described with a separate equation.  
The Laplace transformation can be used as a powerful tool in finding solutions for such 
systems by turning the differential equations into normal equations [8]. Overall, the procedure 
is: 
1) Use the Laplace transformation to replace the differential equations by normal (non-
differential) equations on the so-called Laplace transforms. 
2) Solve these equations to obtain the solutions for the Laplace transforms. 
3) Rewrite the solutions into a form that can be inversely transformed without too much 
difficulty. 
4) Perform inverse Laplace transformation to obtain the solution to the original problem, 
i.e. to solve the differential equations. 
Shortly, Laplace transformation is a mathematical operation which changes a t-dependent 
function into an s-dependent one according to a general rule: 
  
 𝐹(𝑠) = ℒ(𝑓(𝑡)) = ∫ 𝑓(𝑡) · 𝑒−𝑠∙𝑡
∞
0
𝑑𝑡.      {eq. 5} 
The function F(s) is called a Laplace transform. The variable s is abstract and has no obvious 
interpretation, but is mathematically needed to avoid loss of information: One function is 
transformed into another function, allowing inverse transformation (see below). Such inverse 
transformation would not be possible if only a single value (rather than a full function) was 
known, e.g. AUC can be calculated from the curve, but the curve cannot be calculated from 
the value of AUC.  
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In the equations, the distinction between letter t and letter s distinguishes original functions 
from Laplace transforms. 
The Laplace transformation is linear: 
  
 ℒ(𝑎 · 𝑓(𝑡) + 𝑏 · 𝑔(𝑡)) = 𝑎 · ℒ(𝑓(𝑡)) + 𝑏 · ℒ(𝑔(𝑡))   {eq. 6} 
Noteworthy, the Laplace transform of a derivative has a simple relation to the transform of the 
original function: 
 ℒ(𝑓′(𝑡)) = 𝑠 · ℒ(𝑓(𝑡)) − 𝑓(0),       {eq. 7} 
where f(0) is the value of the function for t=0 (initial value).  
Thus, Laplace transformations can be used to change a problem of differential equations into 
a problem of non-differential equations. Solving these equations yields the Laplace transforms 
F(s).  
The last step is inverse transformation to obtain the solutions f(t) to the original problem:
 ℒ (−1)(𝐹(𝑠)) = 𝑓(𝑡).        {eq. 8} 
 
However, inverse Laplace transformation is in general far from easy, which is the reason for 
step 3 in the outlined procedure. Tables exist for a number of inverse transformations, so step 
3 typically consist of rewriting F(s) into a linear combination of such known results.  
In pharmacokinetics of tracers, the involved functions are most often exponentials, allowing 




       {eq. 9} 
with inverse transform: 
 ℒ (−1) (
1
𝑠+𝑎
) = 𝑒−𝑎·𝑡.        {eq. 10} 
 
The linearity of the Laplace transformation tells us that if the solution for the transforms can 
be written as a sum of simple fractions A/(s+a) then the solution for the original equations 
will be a sum of exponentials A·exp(-a·t). 
For simplicity of notation, the independent variable is sometimes written as index, e.g. ft and 







Figure 1: The universal two-compartment model. See the Introduction for the explanations of 
the symbols used.  
 
Setup of equations 
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,      {eq. 12} 
where the dQi/dt are the derivatives and the Qti are the sought variables (quantities of the 
drug) related to the concentrations with a formula: 
ititi VQC /= .  
 
Step 1: Laplace transformations 
































.      {eq. 14} 





































,     {eq. 15} 
where the left-side consists of one column matrix (“Q-zero” column) and the main matrix can 















       {eq. 16} 
in which (according to the rules of multiplying of matrices) the first column is the Qs1-column 
and the second is Qs2.  
 
Step 2: Solving for Laplace transforms  
Linear equations on matrix form can be solved as ratios of determinants (Cramer’s formulas). 
For the 2-C system, the main matrix A was given above. The determinant of this 2×2 matrix is 
a quadratic polynomial: 
( ) 2112121
2det kkKKKKssA −+++= .     {eq. 17} 
 














1        {eq. 18} 
whose determinant is: 
2120210101det kQKQQsAQ ++=      {eq. 19} 








1= .         {eq. 20} 

















AQ ,       {eq. 21} 









2= .         {eq. 23} 
 






































    {eq. 24} 
 
Step 3: Rewriting of the Laplace transforms 
The above expressions are the solutions for the Laplace transforms, but inverse transformation 
is far from obvious. However, as noted earlier, if Qs can be rewritten as a sum of terms on the 
form A/(s+a), then inverse transformation will be simple. 
In both Qs1 and Qs2, the numerator is a linear expression of s, and the denominator is a 
quadratic expression of s (namely the common value det A). As a first step, the denominator 
(the polynomial {eq. 17}) can be factorized: 
( ) ( ) ( )2121122121
2det bsbskkKKKKssA ++=−+++= ,   {eq. 25} 
where –b1 and –b2 are the roots of the quadratic function; this non-standard form of the 
factorized polynomial is chosen so that the resulting formulas better fit the next steps. The 
roots can be found either by solving of the quadratic equation or by use of the Vieta equations 
resulting from {eq. 25}: 
2121 KKbb +=+         {eq. 26} 
20101220211021 kkkkkkbb ++=      {eq. 27} 




∙ (𝐾1 + 𝐾2 ∓√(𝐾1 + 𝐾2)2 − 4 ∙ (𝑘21 ∙ 𝑘10 + 𝑘12 ∙ 𝑘20 + 𝑘20 ∙ 𝑘10)) 
 {eq. 28} 
 
Which solutions becomes b1 and which b2 is a matter of choice. When the minus sign is 
applied for b1 and the plus sign for b2 then the expressions have b1 < b2, which in the final 
result will make b1 part of the most slowly decaying exponential.  
The system of transforms becomes: 
( ) ( )


































.      {eq. 29} 
Each of these fractions can be decomposed into a sum of simple fractions according to the 
method introduced by Oliver Heaviside: 




















= ,   {eq. 30} 
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where A1 and B2 are variables to be found according to an algorithm presented below. This 
method can be used with only some exceptions which, in turn, are not expected to occur in the 
compartment models.  
Multiplying by the denominator of the left side gives: 
( ) ( )2211212021010 bsBbsAkQKQQs +++=++ ;   {eq. 31} 
The equation should be valid for all values of s. Setting s = –b2 yields: 
( ) ( ) ( )22212121202210 bbBbbAkQbKQ +−++−=+−    {eq. 32} 
and hence: 











= .       {eq. 34} 
Similarly, setting s = –b1 yields:  











= .       {eq. 36} 
 
Step 4: Inverse transformation to find the solution for the original problem 
The Laplace transform for compartment 1 is now on the form: 
 












=      {eq. 37} 
Accordingly, the tracer quantity as a function of time is: 
 ( ) ( )tbBtbAQs −+−= 12211 expexp     {eq. 38} 
A similar procedure should be performed for compartment 2.  
 
After division of the formulas by the volume of the respective compartment, one receives the 


























































= .       {eq. 43} 
 
Readers preferring a different notation, e.g. plasma concentration on the form A·exp(-α·t) + 
B·exp(-β·t), are welcome to rewrite in this notation. The only pitfall could be the choice of – 





Numerical verification for 2-C model 
Verification of the above derived analytical model followed by the comparison of the 
concentrations obtained with the analytical and numerical (Runge-Kutta second order, RK2) 
models within a time window of zero to 300 (in the below presented examples for 2-C and 
higher models, all the faster decaying components of the time-concentration curve are 
comparable to the slowest-decaying in the time point zero, but lower by several orders of 
magnitude in the time point 300). For RK2 (the algorithm – see Table 1), the concentrations 
were obtained within this time window in consecutive time steps Δt. The error was calculated 
as the quotient of the concentrations: analytic by numeric; thus, an error-free method would 
correspond to the quotient of exactly one. Several combinations of micro-constants have been 
tested and gave comparable results; the set below is an example.  
 
Table 1: The RK2-algorithm used for testing of the formulas in the 2-C model.  
Compartment 1; initial condition:  
Q10 (given) 
and then: 







*221*11)1(2 QkQKm +−=  
tmQQ AB += )1(211  
Compartment 2; initial condition:  
Q20 (given)  
and then: 
AA QkQKm 11222)2(1 +−=  




*112*22)2(2 QkQKm +−=  




1. Input values: 
V1= 8100, V2= 5400 (and hence ECV= 13 500), Cl12= 125, Cl10= 100, Cl20= 0, Q10= 
20 000 000, Q20= 0.  
2. Elimination rate constants:  
- with eq. 4 one receives k10= 0.012345679, k20= 0, k12= 0.015432099, k21= 
0.023148148; 
- with eq. 11 one receives: K1= 0.027777778, K2= 0.023148148.  
3. Calculation of the macro-constants bi (eq. 28): b1= 0.006421354, b2= 0.044504572.  
4. Calculation of the macro-constants ci and di (eqs. 40-43): c1= 1084.486253, c2= 
1384.649549, d1= 1500.816479, d2= -1500.816479.  
5. The quotients of concentrations (analytical result over numerical result) for Δt= 0.01: 
- compartment 1: maximal 1.000443465 (in t= 300), minimal 1.0000000 (t= 0), 
- compartment 2: maximal 1.000118681 (t= 300), minimal 0.999722267 (t= 0.01).  
6. The quotients of concentrations for Δt= 0.1: 
- compartment 1: maximal 1.00444 (in t= 300), minimal 1.0000000 (t= 0), 
- compartment 2: maximal 1.001185 (t= 300), minimal 0.99723 (t= 0.1).  
 
Thus, a very good agreement was found between results of the analytical derivation and 
results of the numerical calculation, with a quotient deviating less than 1% from the ideal 






Three-compartment universal model 
 
 
Figure 2: Universal 3-C model discussed in this study. If exchange between all compartments 
is possible (all k are >0), this is a cyclic model. Under assumption that compartment 1 is the 
central compartment, k23=k32=0 for the mammillary model (parallel compartments); for the 
catenary model (serial compartments), k13=k31=0.  
 
Setup of equations 
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,     {eq. 45} 
 
Step 1: Laplace transformation 























.    {eq. 46} 
 
















































































.     {eq. 48} 
 
Step 2: Solving for Laplace transforms  







































































AQ      {eq. 51} 
 
























3= .        {eq. 54} 
 
In the later factorisation of det A there will be a minus sign due to the odd number of rows 
containing a negatively signed s (cf. eq. 48):  
 
( ) ( ) ( )321det bsbsbsA +++−= .       {eq. 55} 
 
Instead of keeping this minus sign, we have chosen to calculate –det A, as well as  –det AQi. 
This makes no difference in the fractions eq. 52-54, as the changed signs cancel each other. 
 
The negative determinant of the main matrix is: 









 {eq. 56} 
 
The other negative determinants are: 
( )




















 {eq. 58} 
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 {eq. 59} 
 
 
The solution of the entire equation system is then: 
 
( )
( ) ( ) ( )












= {eq. 60} 
 
( )
( ) ( ) ( )












= {eq. 61} 
 
( )
( ) ( ) ( )












= {eq. 62} 
 
 
Step 3: Rewriting of the Laplace transforms 
Again, we should rewrite the transforms Qs as sums of simple fractions, 1/(s+bi). Basic 
relationships (derived from the Vieta formulas): 
2312313212121331232313213210 kkkkkKkKkKKbb −−−−−==
322331132123132213132211 kKbba −++=++  
3213212 KKKbbba ++=++=        {eqs. 63-65} 
The solution of these equations involves finding roots of third-degree polynomial. There are 










        {eq. 66} 
for k=0,1,2.  
 
A number of the following auxiliary variables have been defined: 
3/221 aap −=          {eq. 67} 
021
3
2 3/27/2 aaaaq +−=        {eq. 68} 
( )27/31 pr −=          {eq. 69} 
3/1















         {eq. 71} 
For brevity, the numerators are stated only in the final results below. 
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Step 4: Inverse transformation to find the solution for the original problem 
The final results for the concentrations (after divisions Ci = Qi/Vi) become: 
 
 
( ) ( ) ( )
( ) ( ) ( )














































     {eq. 73} 
 


















     {eq. 74} 
 








































     {eq. 76} 
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     {eq. 77} 
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     {eq. 81} 
 
Numerical verification of the 3-C results 
The verification was performed analogically as for the 2-C model. The numerical algorithm is 
presented in Table 2.  
 
Table 2: The RK2-algorithm used for testing of the formulas in the 2-C model. 
Compartment 1; initial condition:  
Q10 (given) 
and then: 







*331*221*11)1(2 QkQkQKm ++−=  
tmQQ AB += )1(211  
Compartment 2; initial condition:  
Q20 (given) 
and then: 







*332*112*22)2(2 QkQkQKm ++−=  
tmQQ AB += )2(222  
Compartment 3; initial condition:  
Q30 (given) 
and then: 







*113*223*33)3(2 QkQkQKm ++−=  




1. Input values: V1= 3000, V2= 2000, V3= 5000, Q10= 20 000 000, k10= 0.003333, k20= 
0.025, k30= 0.012, k12= 0.166667, k21= 0.25, k13= 0.033333, k31= 0.02, k23= 0.2, k32= 
0.08.  
2. Macro-constants: b1= 0.011882, b2= 0.173534, b3= 0.604917, c1= 4138.613, c2= 
2602.983, c3= -74.9293, d1= 3956.416, d2= 857.6132, d3= 185.9709, e1= 3988.164, e2= 
-1961.02, e3= -27.1427.  
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3. The error calculation for the respective compartments, Δt= 0.1: 
- compartment 1: minimal 0.99999, maximal 1.000000, 
- compartment 2: minimal 0.999988, maximal 1.000000, 





General remarks on the 2-C and 3-C models 
 
The models considered above have no preferred or central compartment, e.g. allowing for the 
possibility of initial injection into all compartments. Accordingly, a kind of symmetry can be 
noticed among the formulas for different compartments. 
In practice, however, a parallel injection into multiple compartments seems a rare 
phenomenon. The above formulas could be remarkably simplified if the initial amounts of the 
drug were set to zero in all except for one compartment. Further simplification will result if 
some of the k-values are assumed to be zero, e.g. reduction of the cyclic model to mammillary 





Four-compartment models  
 
The above remarks on possible simplification allow reducing the necessary calculations for a 
universal 4-C model just to injection into the compartment number 1. As the model is 
otherwise universal, a simple change of numbering will handle the case where e.g. 
compartment 2 is the only compartment initially containing the drug. However, the algorithm 
for the 4-C model found in the Supplementary Material can be set up with non-zero starting 
values for any compartment. 
 
The (simplified) derivation follows according to the schema presented above for the 2-C and 
3-C. The most important steps are summarized in the following. 
 
Main matrix and determinant 









































































   {eq. 83} 












14 =a  
 
























































Solution of the polynomial allows presenting the determinant as a product: 
( )( )( )( )4321det bsbsbsbsA ++++=      {eq. 90} 
 
Other determinants 

































































= ,        {eq. 95} 
where i denotes the number of the respective compartment (from 1 to 4).  
 
































iit tbfC        {eq. 99} 
 
where:  
( ) ( ) ( ) ( )























( ) ( ) ( ) ( )
























( ) ( ) ( ) ( )
























( ) ( ) ( ) ( )



















































































































































































































































































































































































The verification of the derived formulas followed as for the 2- and 3-C models. The numerical 
algorithm is presented in Table 3.  
 
Table 3: Numeric model (RK2) used for verification of the analytical 4-C model.  
Compartment 1; initial condition: Q10 (given, >0), and then: 







*441*331*221*11)1(2 QkQkQkQKm +++−=  
tmQQ AB += )1(211  
Compartment 2; initial condition: 020 =Q , and then: 







*442*332*112*22)2(2 QkQkQkQKm +++−=  
tmQQ AB += )2(222  
Compartment 3; initial condition: 030 =Q , and then: 







*443*113*223*33)3(2 QkQkQkQKm +++−=  
tmQQ AB += )3(233  
Compartment 4; initial condition: 040 =Q , and then: 








*334*224*114*44)4(2 QkQkQkQKm +++−=  
tmQQ AB += )4(244  
 
Example 
1. Input values: V1= 3000, V2= 1000, V3= 4000, V4= 5000, Q10= 20 000 000, k10= 
0.033333, k20= 0.01, k30= 0.005, k40= 0.006, k12= 0.066667, k21= 0.2, k13= 0.1, k31= 
0.075, k14= 0.166667, k41= 0.1, k23= 0.1, k32= 0.025, k24= 0.2, k42= 0.04, k34= 0.025, 
k43= 0.02.  
2. Calculated macro-constants: b1= 0.011985, b2= 0.162998, b3= 0.42268, b4= 0.575005, 
c1= 1388.721, c2= 62.4713, c3= 3816.194, c4= 1399.281, d1= 1451.115, d2= 85.5152, 
d3= 3158.319, d4= -4694.95, e1= 1502.112, e2= -437.644, e3= -1085.88, e4= 21.41068, 
f1= 1473.612, f2= 304.7205, f3= -1894.33, f4= 115.9929.  
3. Error calculation for the respective compartments for Δt= 0.1: 
- compartment 1: minimal 0.999998, maximal 1.000254, 
- compartment 2: minimal 0.999165, maximal 1.000011,  
- compartment 3: minimal 0.999731, maximal 1.000000,  









When the pharmacokinetics of a drug in the body is to be studied, understood and described, 
it is often useful to focus on a limited number of organs or states, each of which represented 
by a "compartment". Typically, the important compartments and possible interactions are 
theorized (the model), and a concentration curve from e.g. the blood is known from 
measurements (the input). A solution to the model will then be the strengths of the transfer 
rates between compartments, possibly along with concentrations curves for drugs in all 
compartments. These results allow the researcher to evaluate where the drug goes, for how 
long, and through which interactions. 
 
While solutions can surely be used without full understanding of the mathematics behind, 
some understanding is generally helpful. Treating the solution as a "black box" not just limits 
understanding, but can also increase the risk of drawing fragile conclusions. Understanding is 
not a guarantee against mistakes, but it can be a valuable component in drawing sound and 
robust conclusions, as well as in spotting pitfalls. 
 
The above examples of universal 2-C, 3-C and 4-C models show that derivation of higher 
compartment models, as a five-compartment one, although possible, would meet the 
following problems: 
1. Complexity of the intermediate and the final formulas – this could be, however, alleviated, 
if a proper computer algorithm were used. 
2. Necessity of solution of a higher-degree polynomial; according to the Abel-Ruffini 
theorem, however, an algebraic, analytic solution for quintic hexanomials or higher 
polynomials cannot be achieved except for some special cases which, in turn, are not expected 
 20 
to occur in the discussed compartment models. Instead, application of iterative algorithms 
would be inevitable.  
 
The parallel presented numeric RK2 models can be an alternative for the derived analytic 
models. In case of typical values of micro-constants and for time step (Δt) of 0.1 second, the 
relative difference between the analytic and the numeric solution will typically be less than a 
few per mille; a (reasonable) shortening of the time step and/or applying a more accurate (but 
also mathematically more complex) numeric model, as Runge-Kutta fourth order, would 
further reduce the errors. Such a numeric model consists of many (number of time units 
multiplied by the number of time steps per the unit) systems of equations, but can be built 
using a common commercially or even free available software and a more modern personal 
computer.  
 
A more basic problem, however, is that a model with many parameters need data of both high 
quantity and quality to obtain stable results. A universal model with many compartments is 
very prone to instability, where calculated parameters depend on small variations in the input 
data. Thus, even a mathematically correct result may contain very little information about the 
modelled system. Put another way: A more complex model is not necessarily a better model.  
 
This should be remembered already when going from a 2-C to a 3-C model, or from a 3-C to 
a 4-C model. On the other hand, it should be remembered that for modelling, the most basic 
measure of “complexity” (and following risk of instability) is not the number of 
compartments, but the number of fitted parameters. If some of the k-values are restricted to 
zero, this helps reduce complexity of the model. There may also be cases where a non-zero 
but fixed k-value is used, e.g. an independently known value. For example, if a drug with 
well-established 3-C model was not injected intravenously but given orally, a gastro-intestinal 
(fourth) compartment could be defined, with a transfer rate (outgoing k-value) set to a 
physiologically reasonable value. It will of course be wise to verify that the important results 
are relatively insensitive to small changes in the values chosen for the fixed k-parameters. 
 
The quality of data must also be considered when the allowed complexity of the model is 
decided. For clinical pharmacokinetics, the known inputs are often the initial amount of drug 
and measurements of drug concentration within one compartment at a series of time points. A 
first step can then be to determine the macro-constants from {eq. 1}, e.g. by the “peeling-off” 
or “curve-stripping” procedure [9, 10], where the slowest exponential is determined from late 
points and subtracted from the earlier concentration data points. The process is then repeated 
to determine the second-slowest exponential, etc. Dunne [10] pointed out that the 
determination of the early exponentials can be unstable if the exponential decay rates are not 
very clearly separated, and provided a more robust algorithm. Still, the quality of the time-
concentration curve will depend on the quality of the input data.  
 
In summary, even the best real-world data contain some element of noise, so even with a 
perfect model (which is in itself unlikely), the result should be critically examined. An in-
depth evaluation of model stability is beyond the scope of this paper, but a good starting point 
can be to critically test the model. If a small change in input can result in a non-ignorable 







In this paper we have attempted to provide tools for kinetic modelling with compartment 
models of up to 4 compartments. Performance of kinetic modelling is partly an art, but even 
art requires tools and craftsmanship in order to be expressed. The development of 
craftsmanship is the responsibility of the artist, but understanding of the tools can be a help in 
this process. We hope that we have not just presented final results, but also presented the tools 
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Solution of quartic pentanomials (adopted from Shmakov [11])  
 










40 xaxaxaxaxa ++++=  
into two quadratics: 
 22 
( )( )22211240 hxgxhxgxa ++++= , 
which can be easily solved.  
































where a, b, c and d are the coefficients in the monic form: 
0234 =++++ dxcxbxax  
 
1. Calculation of the coefficients of the monic polynomial: 
43 /aaa=  
42 /aab=  
41 /aac=  
40 /aad=  
 
2. Resolvent cubic ( 0
23 =+++ cubcubcub dyyby ): 
2A: coefficients: 
bbcub −=  













27/31 pr −=  
































The other two solutions of the cubic (for k=1 and k=2) lead to the same final solutions.  
 
3. Equations G ( 0
2 =++ gg cgbg ) and H ( 0
2 =++ hh chbh ):  
3A: coefficients 
abg −=  
ybcg −=  
ybh −=  
dch =  
3B: solution 
 23 
ggg cb −= 4
2
 
hhh cb −= 4
2
 








































4. Establishing and solution of the ultimate quadratics: 
Checking the third equation of the initial system: 
if 
chghg kn =+ 21  
then 
khh =1  and  nhh =2 , 
else if 
chghg nk =+ 21  
then 








Computer algorithm for calculation of macro-constants from micro-constants in 2-, 3- and 4-





below, there is a project of such a letter. I tried to explain additionally why it had occurred. Is 
it helpful or better not?  
 
About the order of the terms in the equations: I tried to make it more comprehensible for a 
reader – in my sense, of course ☺ . Just, if anyone were so patient to read the terms, he/she 
could perhaps see the “pathway” of the transport between the compartments. Hence, for 
example, k14*k43*k34 (pathway), instead of k14*k34*k43 (increasing numbers).  
 
In a book on pharmacokinetics, I saw a statement that the terms are the sum of all possible 
permutations of k minus the “loop-forming” terms. In the 3-C, everything seems obvious, i.e. 
(eq. 63),  
a0= K1*K2*K3 – K1*k23*k32 (example of a short loop k23*k32) – k12*k23*k31 (a long 
loop) – other loops.  
 
In the 4-C, however, it looks more sophisticated like (eq. 89):  
a0= K1*K2*K3*K4 (“main term”) - … 
 
There are not only just more loops. Note, that K1 is a sum of k10+…+k14, likewise K2 and 
other “big Ks”. Then, if you subtract from the main term the exemplary two short loops: 
K2*K3*k14*k41 and K1*K4*k23*k32,  
then you subtract the double loop: 
k23*k32*k14*k41 
two times. Thus, at the end, you have to add this double loop to the equation.  
 










Erratum to “Derivation and presentation of formulas for drug concentrations in two-, 
three- and four-compartment pharmacokinetic models” Journal of Pharmacological and 
Toxicological Methods 100 (2019) 106621] 
 
Unfortunately, the paper contained errors in several equations. Fortunately, these errors did 
not affect the final results, and did not influence the algorithms in the supplementary material. 
The corresponding corrections are given below. The authors apologize for the errors. 
 
The affiliation of author Lars Jødal should be: Dept. of Nuclear Medicine, Aalborg University 
Hospital, Aalborg, Denmark. 
  
Errors in the equations (31)-(38), 2-C model:  
In the decomposition of the fractions into simple ones needed for the inverse Laplace 
transformation, the (s+b1) term was swapped with (s+b2); thus, the eight equations were 
written erroneously. However, this did not influence the final results of the model (eqs. 39-
43). The text describing equation (31) to equation (38) should be:  
 
 
Multiplying by the denominator of the left side gives: 
𝑠 · 𝑄10 + 𝑄10 · 𝐾2 +𝑄20 · 𝑘21 = 𝐴1 · (𝑠 + 𝑏2) + 𝐵2 · (𝑠 + 𝑏1);   (31)  
The equation should be valid for all values of s. Setting s = –b2 yields: 
𝑄10 · (𝐾2 − 𝑏2) + 𝑄20 · 𝑘21 = 𝐴1 · (−𝑏2 + 𝑏2) + 𝐵2 · (−𝑏2 + 𝑏1) (32)  
and hence: 





.        (34)  
Similarly, setting s = –b1 yields:  





.        (36)  
Step 4: Inverse transformation to find the solution for the original problem 
The Laplace transform for compartment 1 is now on the form: 






       (37) 
Accordingly, the tracer quantity as a function of time is: 






Errors in the 4-C model:  
 
Equation 88 should be: 
𝑎1 = 𝐾1 · (𝐾2 · 𝐾3 +𝐾2 · 𝐾4 + 𝐾3 · 𝐾4 − 𝑘34 · 𝑘43 − 𝑘24 · 𝑘42 − 𝑘23 · 𝑘32) 
+𝐾2 · (𝐾3 · 𝐾4 − 𝑘13 · 𝑘31 − 𝑘14 · 𝑘41 − 𝑘34 · 𝑘43) 
−𝐾3 · (𝑘12 · 𝑘21 + 𝑘14 · 𝑘41 + 𝑘24 · 𝑘42) 
−𝐾4 · (𝑘12 · 𝑘21 + 𝑘13 · 𝑘31 + 𝑘23 · 𝑘32) 
−𝑘12 · (𝑘23 · 𝑘31 + 𝑘24 · 𝑘41) 
 26 
−𝑘13 · (𝑘32 · 𝑘21 + 𝑘34 · 𝑘41) 
−𝑘14 · (𝑘42 · 𝑘21 + 𝑘43 · 𝑘31) 
−𝑘23 · 𝑘34 · 𝑘42 − 𝑘24 · 𝑘43 · 𝑘32 
 
Equation 89 should be:  
𝑎0 = 𝐾1 · (
𝐾2 · 𝐾3 · 𝐾4 − 𝐾2 · 𝑘34 · 𝑘43 − 𝐾3 · 𝑘24 · 𝑘42 − 𝐾4 · 𝑘23 · 𝑘32
−𝑘23 · 𝑘34 · 𝑘42 − 𝑘24 · 𝑘43 · 𝑘32
) 
−𝐾2 · (𝐾3 · 𝑘14 · 𝑘41 + 𝐾4 · 𝑘13 · 𝑘31 + 𝑘13 · 𝑘34 · 𝑘41 + 𝑘14 · 𝑘43 · 𝑘31) 
−𝐾3 · (𝐾4 · 𝑘12 · 𝑘21 + 𝑘12 · 𝑘24 · 𝑘41 + 𝑘14 · 𝑘42 · 𝑘21) 
−𝐾4 · (𝑘12 · 𝑘23 · 𝑘31 + 𝑘13 · 𝑘32 · 𝑘21) 
−𝑘12 · 𝑘23 · 𝑘34 · 𝑘41 − 𝑘12 · 𝑘24 · 𝑘43 · 𝑘31 
−𝑘13 · 𝑘34 · 𝑘42 · 𝑘21 − 𝑘13 · 𝑘32 · 𝑘24 · 𝑘41 
−𝑘14 · 𝑘43 · 𝑘32 · 𝑘21 − 𝑘14 · 𝑘42 · 𝑘23 · 𝑘31 
+𝑘12 · 𝑘21 · 𝑘34 · 𝑘43 + 𝑘13 · 𝑘31 · 𝑘24 · 𝑘42 + 𝑘14 · 𝑘41 · 𝑘23 · 𝑘32 
 
Equation 93 should be: 
𝑑𝑒𝑡𝐴𝑄3 = 𝑠
2 · 𝑄10 · 𝑘13 + 𝑠 · 𝑄10 · (𝐾2 · 𝑘13 + 𝐾4 · 𝑘13 + 𝑘12 · 𝑘23 + 𝑘14 · 𝑘43) 
+𝑄10 · (
𝐾2 · 𝐾4 · 𝑘13 + 𝐾2 · 𝑘14 · 𝑘43 + 𝐾4 · 𝑘12 · 𝑘23 + 𝑘12 · 𝑘24 · 𝑘43 + 𝑘14 · 𝑘42 · 𝑘23
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